Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.

MLA

Jesmin, Subrina, et al. “Effects of Endothelin Receptor Antagonist on Expression of AT1 and AT2 Receptors in the Heart of SHR-SP.” Journal of Cardiovascular Pharmacology, vol. 44 Suppl 1, Nov. 2004, pp. S59–63. EBSCOhost, https://doi.org/10.1097/01.fjc.0000166223.57970.5f.

APA

Jesmin, S., Sakuma, I., Togashi, H., Yoshioka, M., Hattori, Y., Kitabatake, A., & Miyauchi, T. (2004). Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP. Journal of Cardiovascular Pharmacology, 44 Suppl 1, S59–S63. https://doi.org/10.1097/01.fjc.0000166223.57970.5f

Chicago

Jesmin, Subrina, Ichiro Sakuma, Hiroko Togashi, Mitsuhiro Yoshioka, Yuichi Hattori, Akira Kitabatake, and Takashi Miyauchi. 2004. “Effects of Endothelin Receptor Antagonist on Expression of AT1 and AT2 Receptors in the Heart of SHR-SP.” Journal of Cardiovascular Pharmacology 44 Suppl 1 (November): S59–63. doi:10.1097/01.fjc.0000166223.57970.5f.